FollowMyHealth Patient Portal

Stacey L House, MD, PhD

Clinical Instructor, Emergency Medicine
Director of Research, Emergency Medicine
Director of Emergency Care Research Core

Specialty Areas

Emergency Medicine

Board Certifications

Emergency Medicine

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Emergency medicine

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Barnes-Jewish Hospital

1 Barnes-Jewish Hospital Plaza
St. Louis, MO 63110

Office Phone: 314-758-6787
Fax: 314-362-0478

Education

Education

MD: University of Cincinnati College of Medicine 2007
BS: Yale University, New Haven, CT 1999
PhD: University of Cincinnati College of Medicine 2005
Residency: Barnes-Jewish Hospital, St. Louis, MO 2011

Publication & Research

Publication & Research

Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury.

House SL, Castro AM, Lupu TS, Weinheimer C, Smith C, Kovacs A, Ornitz DM

Am J Physiol Heart Circ Physiol. 2016 Mar 1; 310(5)H559-71. doi: 10.1152/ajpheart.00758.2015.

 

PMID:

    26747503

    [PubMed - in process]

Efficacy of a new intravenous β2-adrenergic agonist (bedoradrine, MN-221) for patients with an acute exacerbation of asthma.

House SL, Matsuda K, O'Brien G, Makhay M, Iwaki Y, Ferguson I, Lovato LM, Lewis LM

Respir Med. 2015 Oct; 109(10)1268-73. doi: 10.1016/j.rmed.2015.08.003.

 

PMID:

    26324315

    [PubMed - in process]

 

Fibroblast growth factor 2 is an essential cardioprotective factor in a closed-chest model of cardiac ischemia-reperfusion injury.

House SL, Wang J, Castro AM, Weinheimer C, Kovacs A, Ornitz DM

Physiol Rep. 2015 Jan 1; 3(1)pii: e12278. doi: 10.14814/phy2.12278.

 

PMID:

    25626875

    [PubMed]

PMID:

    25549307

    [PubMed - in process]

 

Repeated dyspnea score and percent FEV1 are modest predictors of hospitalization/relapse in patients with acute asthma exacerbation.

Schneider JE, Lewis LM, Ferguson I, House SL, Liu J, Matsuda K, Johnson K

Respir Med. 2014 Sep; 108(9)1284-91. doi: 10.1016/j.rmed.2014.06.006.

 

PMID:

    25087835

    [PubMed - indexed for MEDLINE]

 

Response.

Lewis LM, Ferguson I, House SL, Aubuchon K, Schneider J, Johnson K, Matsuda K

Chest. 2014 Jun; 145(6)1436. doi: 10.1378/chest.14-0344.

 

PMID:

    24889452

    [PubMed - indexed for MEDLINE]

 

Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy.

Cilvik SN, Wang JI, Lavine KJ, Uchida K, Castro A, Gierasch CM, Weinheimer CJ, House SL, Kovacs A, Nichols CG, Ornitz DM

PLoS One. 2013; 8(12)e82979. doi: 10.1371/journal.pone.0082979.

 

PMID:

    24349409

    [PubMed - indexed for MEDLINE]

 

Albuterol administration is commonly associated with increases in serum lactate in patients with asthma treated for acute exacerbation of asthma.

Lewis L, Ferguson I, House SL, Aubuchon K, Schneider J, Johnson K, Matsuda K

Chest. 2014 Jan; 145(1)53-9.

 

PMID:

    23949578

    [PubMed - indexed for MEDLINE]

 

Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels.

Manning JR, Carpenter G, Porter DR, House SL, Pietras DA, Doetschman T, Schultz Jel J

Growth Factors. 2012 Apr; 30(2)124-39. doi: 10.3109/08977194.2012.656759.

 

PMID:

    22304432

    [PubMed - indexed for MEDLINE]

 

Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase.

House SL, House BE, Glascock B, Kimball T, Nusayr E, Schultz JE, Doetschman T

Mol Cell Pharmacol. 2010; 2(4)143-154.

PMID:

    21274419

    [PubMed]

 

The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2.

House SL, Melhorn SJ, Newman G, Doetschman T, Schultz Jel J

Am J Physiol Heart Circ Physiol. 2007 Jul; 293(1)H354-65.

 

PMID:

    17337596

    [PubMed - indexed for MEDLINE]

 

Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade.

House SL, Branch K, Newman G, Doetschman T, Schultz Jel J

Am J Physiol Heart Circ Physiol. 2005 Nov; 289(5)H2167-75.

 

PMID:

    16040717

    [PubMed - indexed for MEDLINE]

 

Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.

House SL, Bolte C, Zhou M, Doetschman T, Klevitsky R, Newman G, Schultz Jel J

Circulation. 2003 Dec 23; 108(25)3140-8.

 


 

 

 

Areas of Research Interest

Cardiac ischemia-reperfusion injury, cardioprotection and cardiac repair, fibroblast growth factors, acute myocardial infarction, emergency care research